JP2024528417A5 - - Google Patents
Info
- Publication number
- JP2024528417A5 JP2024528417A5 JP2023577564A JP2023577564A JP2024528417A5 JP 2024528417 A5 JP2024528417 A5 JP 2024528417A5 JP 2023577564 A JP2023577564 A JP 2023577564A JP 2023577564 A JP2023577564 A JP 2023577564A JP 2024528417 A5 JP2024528417 A5 JP 2024528417A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotides
- nucleotide
- chain
- dsrna agent
- antisense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163214220P | 2021-06-23 | 2021-06-23 | |
| US63/214,220 | 2021-06-23 | ||
| US202163274248P | 2021-11-01 | 2021-11-01 | |
| US63/274,248 | 2021-11-01 | ||
| PCT/US2022/034765 WO2022271972A1 (en) | 2021-06-23 | 2022-06-23 | Irna compositions and methods for silencing filamin a (flna) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528417A JP2024528417A (ja) | 2024-07-30 |
| JP2024528417A5 true JP2024528417A5 (https=) | 2025-07-01 |
Family
ID=84545942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577564A Pending JP2024528417A (ja) | 2021-06-23 | 2022-06-23 | フィラミンａ（ｆｌｎａ）をサイレンシングするためのｉｒｎａ組成物および方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240301418A1 (https=) |
| EP (1) | EP4359522A4 (https=) |
| JP (1) | JP2024528417A (https=) |
| WO (1) | WO2022271972A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9840703B2 (en) * | 2013-01-11 | 2017-12-12 | Children's Medical Center Corporation | Methods and compositions for the production of siRNAs |
| EP3171858A4 (en) * | 2014-07-24 | 2018-07-25 | Memorial Sloan-Kettering Cancer Center | Method and composition for targeted delivery of therapeutic agents |
| KR101734652B1 (ko) * | 2015-06-10 | 2017-05-11 | 성균관대학교산학협력단 | 독소루비신 내성 관련 유전자 및 이의 용도 |
| US20190262469A1 (en) * | 2015-09-04 | 2019-08-29 | C. Jeffrey Brinker | Protocells to treat microbial infection and for synergistic delivery |
| MX2020011570A (es) * | 2018-05-07 | 2020-11-24 | Alnylam Pharmaceuticals Inc | Administracion extrahepatica. |
| KR20220115995A (ko) * | 2019-12-13 | 2022-08-19 | 알닐람 파마슈티칼스 인코포레이티드 | 인간 염색체 ９ 개방 판독 프레임 72 (C9orf72) iRNA 제제 조성물 및 이의 사용 방법 |
| US20230045629A1 (en) * | 2020-01-15 | 2023-02-09 | National University Corporation Tokai National Higher Education And Research System | Treatment of progressive supranuclear palsy |
-
2022
- 2022-06-23 WO PCT/US2022/034765 patent/WO2022271972A1/en not_active Ceased
- 2022-06-23 JP JP2023577564A patent/JP2024528417A/ja active Pending
- 2022-06-23 EP EP22829321.3A patent/EP4359522A4/en active Pending
- 2022-06-23 US US18/572,553 patent/US20240301418A1/en active Pending